Quantcha now offering unlimited commission-free options trading.
Quantchabot has detected a promising Synthetic Long Stock trade opportunity for CLOVIS ONCOLOGY (CLVS) for the 15-Jan-2021 expiration period. You can analyze the opportunity in depth over at the Quantcha Options Search Engine.
CLVS was recently trading at $13.89 and has an implied volatility of 61.86% for this period. Based on an analysis of the options available for CLVS expiring on 15-Jan-2021, there is a 68.27% likelihood that the underlying will close within the analyzed range of $4.71-$42.85 at expiration. In this scenario, the average linear return for the trade would be 76.86%.
Upside potential: This synthetic long position offers the same potential benefits and liabilities as a long stock position, but at a discount due to the significant premium at-the-money puts are trading at over calls. In this case, the long call position is opened at a strike of $13.00, which is already $0.89 in the money. An out-of-the-money put at the same strike is sold to finance the call, resulting in a net credit of $0.90 per share. The final position can be considered as having a discount of $1.79 per share over the underlying price of $13.89 for a 12.88% total.
Downside risk: This discount is generally a sign of the stock facing considerable short pressure, and may indicate that the stock has become hard to borrow. However, if you have a long view of the underlying over this period, it could be a good opportunity to benefit from the upside at a major discount.
To analyze this trade in depth, please visit the Quantcha Options Search Engine.
This is an automated post generated based on a market analysis of delayed data at 11/29/2019 10:32:53 AM ET. The analysis does not include brokerage fees or commissions and is not investment advice.